4.4 Article

MORC2/β-catenin signaling axis promotes proliferation and migration of breast cancer cells

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

O-GlcNAcylation of MORC2 at threonine 556 by OGT couples TGF-beta signaling to breast cancer progression

Ying-Ying Liu et al.

Summary: This study reveals the importance of MORC2 O-GlcNAcylation in breast cancer progression. MORC2 is O-GlcNAcylated by OGT at threonine 556, and this modification is required for its role in breast cancer cell migration and invasion. TGF-beta 1 induces MORC2 O-GlcNAcylation through enhancing the stability of GFAT, and O-GlcNAcylated MORC2 is necessary for the transcriptional activation of TGF-beta 1 target genes CTGF and SNAIL. These findings provide evidence for targeting MORC2-dependent breast cancer through blocking its O-GlcNAcylation.

CELL DEATH AND DIFFERENTIATION (2022)

Article Medicine, Research & Experimental

Microrchidia family CW-type zinc finger 2 promotes the proliferation, invasion, migration and epithelial-mesenchymal transition of glioma by regulating PTEN/PI3K/AKT signaling via binding to N-myc downstream regulated gene 1 promoter

Jing Zhang et al.

Summary: The study revealed that MORC2 was significantly upregulated in glioma cells and its inactivation inhibited proliferation, invasion, migration and EMT of glioma cells, while upregulating NDRG1 expression and inactivating PTEN/PI3K/AKT signaling. NDRG1 upregulation suppressed the progression of glioma, partially reversed by MORC2 overexpression.

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2022)

Review Biophysics

MORC2 Interactome: Its Involvement in Metabolism and Cancer

Rohith Kumar Guddeti et al.

Summary: MORC2 is an emerging chromatin modifier that is upregulated in most cancers, playing a significant role in tumorigenesis and tumor metastasis. Recent studies have shown that MORC2 acts as a scaffolding protein, interacting with proteins involved in DNA repair, chromatin remodeling, lipogenesis, and glucose metabolism. It is also highlighted that MORC2 interacts with specific partners involved in metabolic reprogramming and other pathological functions such as cancer progression and metastasis.

BIOPHYSICAL REVIEWS (2021)

Review Oncology

The lingering mysteries of metastatic recurrence in breast cancer

Alessandra I. Riggio et al.

Summary: This review provides an overview of the key factors influencing metastatic recurrence in breast cancer, highlighting critical unanswered questions that need to be addressed.

BRITISH JOURNAL OF CANCER (2021)

Article Oncology

The European cancer burden in 2020: Incidence and mortality estimates for 40 countries and 25 major cancers

Tadeusz Dyba et al.

Summary: This article presents the incidence and mortality estimates for 25 major cancers across 40 individual countries within European areas and the EU-27 for the year 2020. The most common cancers are breast, colorectal, lung, and prostate cancers, which account for half the overall cancer burden in Europe. The estimates provide a basis for setting priorities in cancer-control measures across Europe.

EUROPEAN JOURNAL OF CANCER (2021)

Article Biochemistry & Molecular Biology

The chromatin modifier MORC2 affects glucose metabolism by regulating the expression of lactate dehydrogenase A through a feed forward loop with c-Myc

Rohith Kumar Guddeti et al.

Summary: MORC2, as a glucose-inducible gene, modulates the migration of breast cancer cells through the MORC2-c-Myc-LDHA axis. Overexpression of MORC2 enhances the expression and activity of LDHA, while selective knockdown of MORC2 reduces LDHA expression and activity, leading to decreased cancer cell migration.

FEBS LETTERS (2021)

Article Biotechnology & Applied Microbiology

Circular RNA circDNM3OS Functions as a miR-145-5p Sponge to Accelerate Cholangiocarcinoma Growth and Glutamine Metabolism by Upregulating MORC2

Yongfeng Su et al.

Summary: The study revealed that circDNM3OS promotes CCA growth and glutamine metabolism by regulating the miR-145-5p/MORC2 pathway, with experimental evidence supporting this conclusion.

ONCOTARGETS AND THERAPY (2021)

Review Cell Biology

MORC protein family-related signature within human disease and cancer

Huan Wang et al.

Summary: The microrchidia (MORC) family of proteins is highly conserved and plays diverse biological functions, with a focus on their role as epigenetic regulators and in chromatin remodeling. While originally identified in germ cell development, MORCs are now recognized as disease genes and oncogenes, making them potentially important biomarkers for diagnosis and treatment in human disorders and cancer. The expanding understanding of the MORC family's function has highlighted their potential as targets for developing tools and treatments for human diseases, including cancers.

CELL DEATH & DISEASE (2021)

Article Oncology

Cancer statistics, 2020

Rebecca L. Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2020)

Review Biochemistry & Molecular Biology

Wnt signaling in breast cancer: biological mechanisms, challenges and opportunities

Xiufang Xu et al.

MOLECULAR CANCER (2020)

Article Biochemistry & Molecular Biology

MORC2 regulates DNA damage response through a PARP1-dependent pathway

Lin Zhang et al.

NUCLEIC ACIDS RESEARCH (2019)

Article Oncology

Are 90% of deaths from cancer caused by metastases?

Hanna Dillekas et al.

CANCER MEDICINE (2019)

Article Biochemistry & Molecular Biology

Characterization of molecular mechanisms underlying the axonal Charcot-Marie-Tooth neuropathy caused by MORC2 mutations

Paula Sancho et al.

HUMAN MOLECULAR GENETICS (2019)

Article Biochemistry & Molecular Biology

HSF1, in association with MORC2, downregulates ArgBP2 via the PRC2 family in gastric cancer cells

Yuxin Tong et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2018)

Article Biochemistry & Molecular Biology

Epigenetic restriction of Hippo signaling by MORC2 underlies stemness of hepatocellular carcinoma cells

Tao Wang et al.

CELL DEATH AND DIFFERENTIATION (2018)

Article Multidisciplinary Sciences

Multi-omics profiling of younger Asian breast cancers reveals distinctive molecular signatures

Zhengyan Kan et al.

NATURE COMMUNICATIONS (2018)

Review Cell Biology

The Emerging Role of MORC Family Proteins in Cancer Development and Bone Homeostasis

Guoju Hong et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2017)

Article Genetics & Heredity

Hyperactivation of HUSH complex function by Charcot-Marie-Tooth disease mutation in MORC2

Iva A. Tchasovnikarova et al.

NATURE GENETICS (2017)

Article Clinical Neurology

MORC2 Mutations Cause Axonal Charcot-Marie-Tooth Disease With Pyramidal Signs

Obaid M. Albulym et al.

ANNALS OF NEUROLOGY (2016)

Article Biochemistry & Molecular Biology

System-wide Clinical Proteomics of Breast Cancer Reveals Global Remodeling of Tissue Homeostasis

Yair Pozniak et al.

CELL SYSTEMS (2016)

Article Biochemistry & Molecular Biology

Microchidia protein 2, MORC2, downregulates the cytoskeleton adapter protein, ArgBP2, via histone methylation in gastric cancer cells

Yuxin Tong et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)

Article Biochemistry & Molecular Biology

Cytosolic functions of MORC2 in lipogenesis and adipogenesis

Beatriz Sanchez-Solana et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2014)

Article Biochemistry & Molecular Biology

Glucose-Induced β-Catenin Acetylation Enhances Wnt Signaling in Cancer

Ana Chocarro-Calvo et al.

MOLECULAR CELL (2013)

Article Anatomy & Morphology

Identification and Expression Analysis of a Novel CW-Type Zinc Finger Protein MORC2 in Cancer Cells

Gui-Ling Wang et al.

ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY (2010)

Article Biochemistry & Molecular Biology

Phosphorylation of β-catenin by AKT promotes β-catenin transcriptional activity

Dexing Fang et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2007)

Review Biochemistry & Molecular Biology

Wnt/β-catenin signaling in development and disease

Hans Clevers

Article Biochemistry & Molecular Biology

β-catenin is a downstream effector of Wnt-mediated tumorigenesis in the mammary gland

JS Michaelson et al.

ONCOGENE (2001)